Formal synthesis of (+)-lactacystin from l-serine by Bulman Page, Philip C. et al.
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Philip C. Bulman Page, *a Ross L. Goodyear,a Yohan Chan,a
Alexandra M. Z. Slawin b and Steven M. Allin c
A formal, stereocontrolled synthesis of lactacystin has been completed from t-Bu-O-L-serine, providing the
key intermediate 13, also useful for the generation of a range of C-9 analogues.Introduction
The 20S proteasome is a large barrel-shaped protein comprised
of 28 subunits.1 The primary function of the proteasome
involves the degradation of damaged proteins, a vital compo-
nent of the ubiquitin proteasome pathway. Inhibition of the
proteasome can lead to cell death. This property of the protea-
some has made it a promising target for cancer therapeutics.2
Microbial metabolites have provided a wealth of proteasome
inhibitors (Fig. 1). Lactacystin 1 was discovered in 1991 by
O¯mura through extraction from the cultured broth of Strepto-
myces sp OM-6519,3,4 aer observations that it induced diﬀer-
entiation of the mouse neuroblastoma cell line, a consequence
of proteasome inhibition. Further studies, driven by several
early eﬀorts to prepare lactacystin and analogues, found that
lactacystin undergoes cyclization to the b-lactone omuralide 2,
which inhibits the proteasome5 and can induce apoptosis. The
potential for beta-lactone, gamma-lactam proteasome inhibi-
tors was further highlighted by the discovery of the salino-
sporamides, e.g. 3,6–8 and cinnabaramides, e.g. 4.9 Similar
lactam cores have also been discovered in the metabolite oxa-
zolomycin10 5, which possesses antibiotic activity. A number of
strategies to access these cores to produce natural products and
analogues of high therapeutic value have been reported.11Results & discussion
Our synthetic work has focused on the development of a func-
tionalized lactam core from glycine,12,13 and recently using L-nglia, Norwich Research Park, Norwich,
c.uk
ws, St Andrews, Scotland KY16 9ST, UK
m Trent University, Clion, Nottingham
(ESI) available: Copies of 1H and 13C
RTEP diagrams and X-ray data. CCDC
raphic data in CIF or other electronic
hemistry 2019leucine 6 as a starting material to produce a formal synthesis of
the C9-deoxyomuralide analogue, using the natural chirality of
the amino acid to direct the synthesis.14 Formation of the
carbon skeleton of omuralide was achieved in 4 steps (Scheme
1). Peptide coupling of PMB-protected leucine 7 to the malonic
acid benzyl ester 8 provided the precursor 9 to the key Die-
ckmann cyclization/alkylation step. Cyclization was induced
with TBAF, and subsequent addition of methyl iodide provided
two diastereoisomers. The major, 10b, was isolated and used in
an acylation using Mander's reagent to give 11, thus completing
the carbon skeleton. Six further steps produced pyroglutamate
12, which can be cyclized to give 9-deoxyomuralide in one step.
With this methodology in place, we turned our attention to
a serine-derived route to lactacystin. This would provide
a hydroxy group in the C9 position, which previous SAR studies
have shown to be key for eﬀective proteasome inhibition.
We envisaged that intermediate 13 could be synthesized
from a suitably protected tetramic acid-like core 14 (Scheme 2).
A removable benzyl ester would be used to help direct acylation
of lactam 15 usingMander's reagent; 15 could in turn be formed
using the cyclization/alkylation procedure previously devel-
oped. The Dieckmann cyclization precursor 16 could be
synthesized from peptide coupling of a suitably protected O-t-
Bu-L-serine 17. This starting material was used due to the size of
the t-butyl group, its tolerance towards a wide range of condi-
tions, and because both enantiomers are commercially
available.
PMB protection of the serine derivative 17 was carried out
using a modication of a procedure by Va´zquez using the PMB
sulphite adduct 18.15 We have previously observed14 epimeri-
zation during imine formation, and so a one-pot procedure was
developed. Aer work up, the protected serine 19 could be used
without further purication. Peptide coupling to benzyl
malonic ester 8 provided the Dieckmann cyclization precursor
in 49% yield over the two steps. Analysis using chiral stationary
phase HPLC showed that only negligible epimerization had
occurred at this point, providing 16 in 97% ee (Scheme 3).
With the Dieckmann precursor 16 in hand, we turned our
attention to the tandem cyclization/alkylation step (Scheme 4).RSC Adv., 2019, 9, 30019–30032 | 30019
Fig. 1 Examples of proteasome inhibitors.
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View Article OnlineWhen subjected to the conditions used previously (TBAF in
THF, then MeI addition), the cyclization/alkylation proceeded
with good yield and provided a 10 : 1 ratio of diastereoisomers
15a and 15b, in favour of 15a, where the newly added methyl
group is situated on the same face of the molecule as the t-BuO
group.Scheme 1 Reagents and conditions: (i) p-methoxybenzaldehyde, Et3N, M
93%; (iii) TBAF, THF, r.t., 0.5 h, then MeI, 0 C to r.t., overnight, 10a/b 57%
70%.
30020 | RSC Adv., 2019, 9, 30019–30032Our previous work on the leucine analogue14 showed that
addition of the methyl iodide is in that case preferentially
introduced opposite the isobutyl moiety (Scheme 5). This
outcome was expected due to the bulky nature of the amino acid
group and the assumed planarity of the intermediate. The dia-
stereoisomers were isolated in a 1 : 2 mixture and theeOH, NaBH4, 71%; (ii) NMM, EDAC$HCl, DMAP, CH2Cl2, r.t., overnight,
; (iv) LiHMDS, DMPU, THF, 78 C, 0.5 h, then NCCO2Me, 78 C, 4 h,
This journal is © The Royal Society of Chemistry 2019
Scheme 2
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View Article Onlineobservation was conrmed by single crystal X-ray analysis of 20,
derived from the minor diastereoisomer 10a by PMB removal.
We were therefore surprised to nd that our serine derivative
aﬀorded the diastereoisomers in a 10 : 1 mixture favouring the
diastereoisomer 15a with the methyl group cis to the t-BuO
group, presumably because in forming 15b the benzyl ester unit
is forced nearer to the t-BuO, so raising the transition state
energy of that pathway.
On analysis by chiral HPLC the major diastereoisomer was
found to have a disappointing ee of 44%. Running the reaction
at decreased temperatures provided higher ee at the expense of
yield. Further optimization (Table 1), including increased
reaction times, lower temperatures and the separation of the
cyclization and alkylation steps, achieved ees of up to 79% and
yields of 66%. The ee could be improved further through
recrystallization from isopropanol, which produced 97% ee. We
suspect that the decrease in ee is primarily the result of epi-
merization at the C5 position in themixture of diastereoisomers
15a/b following alkylation, leading to the (presumed) more
stable diastereoisomer 15a. Lower temperatures reduce the
degree of this epimerization, leading to the decreased diaster-
eoselectivities (3 : 1) but higher ees.
During our work with the L-leucine derived analogue 9, we
were able to isolate a 1 : 2 ratio of diastereoisomers 10a and 10b
in 9% ee and 79% ee respectively (Scheme 5).14 Our results with
leucine strongly indicate that the partial racemization occurs
aer the alkylation. If racemization occurred solely beforeScheme 3 Reagents and conditions: (i) 14, NaBH3CN, Et3N, MeOH0 C 1
the 2 steps.
This journal is © The Royal Society of Chemistry 2019alkylation, the ratio of diastereoisomers in the racemic material
should match the ratio of diastereoisomers in the enantiopure
material. As we observed the diastereoisomers in a 1 : 2 ratio at
9% and 79% ee respectively, the vast majority of racemization
must occur aer alkylation. Due to the structural similarity
between our L-leucine-derived lactams and our serine-derived
lactams, it seems likely that the mode of racemization is
analogous.
To investigate the stereoselectivity further, the benzyl ester
was replaced by a methyl counterpart (Scheme 6). Coupling of
19 to the half malonic methyl ester potassium salt in an anal-
ogous procedure to that of 16 proceeded in good yield, to
produce 21. Once treated with our cyclization/alkylation
procedure, NMR analysis showed that the cyclization occurred
eﬃciently, but we found that 22a/b decomposed if le in
contact with silica gel for extended periods of time. Partial
purication was therefore completed with a silica plug to
produce a 3 : 1 mixture of diastereoisomers; the mixture was
treated with CAN removing the PMB group (Scheme 6). The
puried major isomer 23a was obtained as a colourless crys-
talline solid. Analysis by single crystal X-ray diﬀraction showed
that the methyl group was still preferentially added to the same
face as the tert-butoxy group, allowing us to conclude that the
benzyl ester was not the primary inuence on diaster-
eoselectivity in our system.
The system was further investigated by replacing the PMB
group with a phenyl (Scheme 6). Chan–Lam coupling of the6 h (ii) 8, EDAC$HCl,N-methyl morpholine, DMAP, DCM, 16 h; 49% over
RSC Adv., 2019, 9, 30019–30032 | 30021
Scheme 4
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View Article Onlineserine derivative with phenyl boronic acid and subsequent
peptide coupling to the benzyl malonic half ester 8 produced
the Dieckmann cyclization precursor 24. Compound 24 wasScheme 5 Reagents and conditions: (i) CAN, 3 : 1 MeCN/H2O, 84%.
30022 | RSC Adv., 2019, 9, 30019–30032subjected to our cyclization conditions. The methylated
product 25 was produced in a 5 : 1 ratio of diastereoisomers
according to the 1H NMR spectrum, albeit in a low yield,This journal is © The Royal Society of Chemistry 2019
Table 1 Optimization of the Dieckmann cyclization/alkylation giving 15a
Entry Conditions Yield
Ratio of diastereoisomers
15a : 15b ee of 15aa
1 TBAF, THF 2 h then MeI 2 h 62% 10 : 1 44%
2 TBAF, THF 0.5 h, MeI, 0 C to r.t. over 16 h 42% 10 : 1 60%
3 TBAF, THF 0.5 h, MeI, 10 C Trace — 76%
4 TBAF, ether, 5 m, THF MeI, 15 C, 64 h 30% 3 : 1 76%
5 TBAF, ether, 5 m, THF MeI, 12 C, 64 h 66% 3 : 1 79%
a Determined by HPLC on chiral stationary phase by comparison with racemic material using Chiralpak AD-H or Knauer Eurocel 01 columns.
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View Article Onlineperhaps due to the conformation required for cyclization
being more unfavourable. A crystal of the major diastereo-
isomer suitable for X-ray analysis was obtained. Once again,
in the major product the methyl group had been introduced
to the same face as the tert-butoxy.
With 15a in hand, we sought to install the methyl ester
moiety that would eventually form the beta lactone found in
omuralide. Acylation using Mander's reagent at 40 C was
found to produce compound 26 in good yield with no observed
O-acetylation. In addition, only one diastereoisomer could be
observed (Scheme 7). A small drop in ee was observed during
the acylation, to 69%, perhaps due to the presence of small
quantities of the minor diastereomer 15b. Using recrystallized
15a, the ee of 26 was 84%. Single crystal X-ray analysis of 26 was
carried out on both the racemic and enantiomerically pure
(obtained by recrystallization) forms, the latter conrming thatScheme 6 Reagents and conditions: (i) TBAF, ether, 5 m, THF, MeI, 12
MeI, 12 C, 64 h; 11%.
This journal is © The Royal Society of Chemistry 2019the absolute stereochemistry of our C9 centre is as found in
(+)-lactacystin.
Removal of the benzyl ester from 26 by hydrogenolysis led to
tetramic acid derivative 14 as a mixture of diastereoisomers.
The mixture proved unstable towards silica gel and so was used
in the next step without purication. On treatment with S-
methyl p-toluenethiosulfonate 27, in a similar manner to Pat-
tenden,16,17 a 4 : 1 mixture of inseparable diastereoisomers 28a/
b was formed. NOESY experiments conrmed that the major
observed diastereoisomer was the desired one, with the methyl
thioether trans to the t-BuO group (Scheme 8).
Removal of the t-butyl group from 28a would allow comple-
tion of the formal synthesis to form the Corey intermediate
29a.18 Treatment of 28a/b with a 1 : 1 TFA/DCM mixture led to
an inseparable mixture of the diastereoisomers 29a/b in a 2 : 1
mixture aer purication by column chromatography. To ourC, 58 h; 87% (ii) CAN, 3 : 1 MeCN/H2O, 57%, (iii) TBAF, ether, 5 m, THF
RSC Adv., 2019, 9, 30019–30032 | 30023
Scheme 7 Reagents and conditions: (i) LiHMDS, DMPU, THF, 40 C,
0.5 h then MeOCOCN, 3 h, 40 C; 69%.
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View Article Onlinesurprise, analysis by chiral HPLC showed a drop in ee from 84%
to 58% and 41% respectively for 29a and 29b (Scheme 9).
A mechanism for this epimerization did not seem
obvious, and a simpler substrate was synthesized to probeScheme 8 Reagents and conditions (i) Pd(OH)2/C, H2, 35 C, 16 h (ii) 27
30024 | RSC Adv., 2019, 9, 30019–30032the reaction further. Use of methyl iodide as alkylating agent
in place of 27 added a second methyl group to the C7 posi-
tion, giving 30 (Scheme 10). This gem-methylated analogue
of our substrate was chosen for two reasons, to eliminate
a stereogenic centre, which could conrm C5 as the epi-
merizing centre, and to reduce the number of potentially
reactive functional groups. Removal of the t-butyl group
with TFA under the conditions used for 28a/b gave 31 in
racemic form. Further analysis revealed that the stereo-
centre remained unchanged upon treatment of 30 with TFA.
The racemization occurred during preparation for the
purication by column chromatography, where crude 29a/
b was dissolved in DCM and adsorbed onto silica gel,
perhaps a result of a retroaldol process. We were pleased to
nd that changing to a wet loading method, where crude 31
was loaded onto the chromatography column in the eluting
solvent using petroleum ether/ethyl acetate, resulted in
complete preservation of the ee.
Returning to our original system, the 4 : 1 mixture of 28a/
b was treated with TFA/DCM to produce 29a/b. Analysis by 1H
NMR spectroscopy showed retention of the 4 : 1 ratio in the
crude mixture. Silica gel was added, and the NMR spectrum
obtained again, now showing a ratio of 3 : 1.3. Aer leaving
29a/b in contact with the silica gel for 16 h, the 1H NMR
spectroscopy was repeated, the spectrum this time showing
a 3 : 2 ratio. Despite largely preventing the epimerization, we
were unable to separate the diastereoisomers 29a/b eﬃ-
ciently. Because of this problem we changed the order of
deprotection and reduction, aiming to produce the later
Corey intermediate lactam 13 (Scheme 11).18, Et3N, DCM, 4 h (70% over 2 steps).
This journal is © The Royal Society of Chemistry 2019
Scheme 9 Reagents and conditions: (i) TFA/DCM 1 : 1, 1.5 h; 76%.
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View Article OnlineSodium borohydride reduction of the inseparable 4 : 1
diastereoisomeric mixture 28a/b led to two separable isomers
32a and 32b in a 4 : 1 ratio. Analysis of the products by HPLC
using a chiral stationary phase indicated ees of 67% and 66%
for 32a and 32b respectively. The desired rst eluting dia-
stereoisomer 32a was recrystallized from IPA, to our delight
providing 32a with 99% ee. Treatment of the ltrate with TFA/Scheme 10 Reagents and conditions: (i) Pd(OH)2/C, H2, 35 C, 16 h (ii) M
Scheme 11 Reagents and conditions (i) (1) Pd(OH)2/C, H2, 35 C, 16 h, (2
32a, 54%, 32b, 13%; (iii) TFA/DCM 1 : 1, 75%.
This journal is © The Royal Society of Chemistry 2019DCM resulted in the desired lactam 13 without further epi-
merization, thus completing our formal synthesis of (+)-lac-
tacystin in six steps from 16.
A formal synthesis of (+)-lactacystin has thus been completed
in six steps from 16. Lactam 13 has also been functionalized by
Corey to give a variety of C9 analogues.19eI, Et3N, DCM, 4 h (46% over 2 steps), (iii) TFA/DCM 1 : 1 67%.
) 27, Et3N, DCM, 4 h (70% over 2 steps); (ii) NaBH4, EtOH, 30 min, 0 C:
RSC Adv., 2019, 9, 30019–30032 | 30025
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View Article OnlineExperimental detail
Benzyl (3S,5S)-3-methyl-5-(2-methylpropyl)-2,4-dioxopyrrolidine-3-
carboxylate 20
Lactam 10a (1.2023 g, 2.83 mmol) was dissolved in a MeCN/
water mixture (3 : 1, 27.6 mL). CAN (8.3 g, 14.22 mmol, 5
equiv.) was added and the solution stirred until complete
consumption of the starting material had occurred (approx. 2
h). The solution was diluted with water (150 mL) and extracted
with ethyl acetate (150 mL  3). The organic layers were
combined and washed with brine (100 mL  2), dried (sodium
sulfate), ltered, and the solvents removed under reduced
pressure. The residue was puried by column chromatography
using petroleum ether (40–60 C)/ethyl acetate (8 : 2) as eluent
to produce 20 as a colourless crystalline solid. (0.725 g, 84%).
Mp 118–124 C; [a]24D ¼ +11.6 (c 2.3, CHCl3) (9% ee); nmax (thin
lm)/cm1: 3209, 2960, 1781, 1748, 1705; 1H NMR (500 MHz,
CDCl3) dH 7.38–7.30 (m, 3H), 7.29–7.23 (m, 2H), 7.02–6.60 (m,
1H), 5.24–511 (m, 2H), 4.18 (dd, J ¼ 9.5, 3.5 Hz, 1H), 1.78–1.68
(m, 2H), 1.53 (s, 3H), 1.43 (m, 1H), 0.96 (d, J ¼ 6.2 Hz, 3H), 0.94
(d, J ¼ 6.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) dC 206.7, 171.9,
165.5, 135.0, 128.8, 128.6, 127.9, 68.1, 61.4, 58.6, 41.3, 25.2, 23.2,
21.5, 15.9; HRMS (NSI-FTMS) m/z [M + NH4]
+ calcd for
[C17H25N2O4]
+ 321.1809, found 321.1812.
Sodium hydroxy(4-methoxyphenyl)methanesulfonate 18 (ref. 15)
p-Methoxybenzaldehyde (20 mL, 0.164 mol, 1.2 equiv.) was
stirred in ethanol (330 mL). An aqueous solution of sodium
sulte (17.56 g, 0.139 mol in 34 mL) was added slowly, forming
a cloudy precipitate. The mixture was stirred for 16 h at 30 C,
then stirred in an ice bath for 2 hours allowing further precip-
itation. The resulting suspension was ltered, and the collected
solid washed with hexane and dried in a vacuum oven to yield
the adduct sulphite 18 as a uﬀy colourless solid (33.72 g, 81%).
Mp 166–168 C (decomp.) (lit20 155–157 C (decomp.)); nmax
(solid)/cm1 3226, 1516, 1249; 1H NMR (500 MHz, DMSO) dH
7.34 (d, J ¼ 8.3 Hz, 2H), 6.79 (d, J ¼ 8.8 Hz, 2H), 5.56 (d, J ¼
5.1 Hz, 1H), 4.87 (d, J ¼ 5.0 Hz, 1H), 3.72 (s, 3H); 13C NMR (126
MHz, DMSO) dC 158.6, 131.6, 129.1, 112.6, 84.7, 55.2.
(S)-Methyl 3-(tert-butoxy)-2-((4-methoxybenzyl)amino)propanoate 19
t-Bu-O-Serine methyl ester hydrochloride 17 (5 g, 23.61 mmol)
was dissolved in methanol (250 mL). The sulte salt 18 (9 g,
37.46 mmol, 1.6 equiv.) was added along with triethylamine (3
mL, 21.52 mmol 0.9 equiv.). The stirred solution was cooled
with an ice bath, and sodium cyanoborohydride (9.09 g,
144 mmol, 6.1 equiv.) added in small portions. The suspension
was kept overnight and allowed to reach room temperature, the
solvents removed, and the residue dissolved in ethyl acetate
(200 mL). The organic solution was washed with equal amounts
of brine, saturated sodium sulte solution, and water, dried
(magnesium sulfate), ltered, and the solvents removed under
reduced pressure to give 19 (5.92 g, 85%), which was used in the
next step without further purication. For analytical purposes,
a portion was puried by column chromatography on silica gel
using petroleum ether (40–60 C)/ethyl acetate (9 : 1) as eluent30026 | RSC Adv., 2019, 9, 30019–30032to yield 19 as a colourless oil. [a]24D ¼23.61 (c 1.05, CHCl3) nmax
(thin lm)/cm1: 3434, 2974, 1743; 1H NMR (500 MHz, CDCl3)
d 7.25 (d, J ¼ 7.5 Hz, 2H), 6.85 (d, J ¼ 8.7 Hz, 2H), 3.83 (d, J ¼
12.8 Hz, 1H), 3.79 (s, 3H), 3.72 (s, 3H), 3.65 (d, J ¼ 12.8 Hz, 1H),
3.60 (dd, J ¼ 8.7, 5.3 Hz, 1H), 3.55 (dd, J ¼ 8.7, 4.9 Hz, 1H), 3.43
(t, J ¼ 5.1 Hz, 1H), 2.14 (s, 1H), 1.14 (s, 9H); 13C NMR (126 MHz,
CDCl3) d 174.1, 158.8, 132.1, 129.7, 113.9, 73.3, 63.3, 61.1, 55.4,
51.8, 51.5, 27.5; HRMS (NSI-FTMS) m/z [M + H]+ calcd for
[C16H26NO4]
+ 296.1856, found 296.1859.
(S)-Benzyl 3-((3-(tert-butoxy)-1-methoxy-1-oxopropan-2-yl)(4-
methoxybenzyl)amino)-3-oxopropanoate 16
Crude amine 19 (5.92 g, 20.05 mmol) was dissolved in anhy-
drous DCM (182 mL) in a ame-dried ask. The benzyl malonic
half ester 8 (11.59 g, 49.89 mmol, 2.5 equiv.) was added along
with EDAC$HCl (10.30 g, 53.72 mmol 2.7 equiv.), DMAP (0.5 g,
4.1 mmol, 0.2 equiv.) and N-methyl morpholine (5.5 mL,
50 mmol, 2.5 equiv.). The solution was stirred for 16 h under an
atmosphere of nitrogen. Aqueous HCl (1 M, 6 mL) was added,
and the solution transferred into a separating funnel, and
washed with water (200 mL) and brine (200 mL). The organic
layer was dried (magnesium sulfate), ltered and the solvents
removed under reduced pressure to give a yellow oil, which was
puried by column chromatography on silica gel using petro-
leum ether (40–60 C)/ethyl acetate (8 : 2) as eluent, to give 16 as
a pale yellow oil. (5.493 g, 49% over the 2 steps) [a]24D ¼23.61 (c
1.05, CHCl3) nmax (neat)/cm
1: 3434, 2974, 1743; 1H NMR (500
MHz, CDCl3) (major conformation) dH 7.40–7.29 (m, 5H), 7.24
(d, J ¼ 8.8 Hz, 2H), 6.86 (d, J ¼ 8.7 Hz, 2H), 5.15 (s, 2H), 4.69 (s,
2H), 4.58 (dd, J ¼ 7.5, 3.4 Hz, 1H), 3.90 (dd, J ¼ 9.7, 7.6 Hz, 1H),
3.80–3.74 (m, 4H), 3.67 (s, 3H), 3.51 (d, J ¼ 15.4 Hz, 1H), 3.43 (d,
J ¼ 15.4 Hz, 1H), 1.06 (s, 9H); 13C NMR (126 MHz, CDCl3) dC
169.7, 167.3, 167.2, 159.1, 128.8, 128.6, 128.4, 128.1, 114.2, 73.4,
67.1, 60.7, 59.7, 55.4, 52.3, 52.1, 41.5, 27.3; HRMS (NSI-FTMS)m/
z [M + H]+ calcd for [C26H34NO7]
+ 472.2330, found 472.2325.
Determination of ee (97% ee) was carried out by HPLC using an
AD-H Chiralpak column 90 : 10 hexane/IPA, 230 nm, 0.8
mL min1, 15 C.
(3S,5S)-Benzyl 5-(tert-butoxymethyl)-1-(4-methoxybenzyl)-3-methyl-
2,4-dioxopyrrolidine-3-carboxylate 15a and (3R,5S)-benzyl 5-(tert-
butoxymethyl)-1-(4-methoxybenzyl)-3-methyl-2,4-dioxopyrrolidine-
3-carboxylate 15b
Compound 16 (1.605 g, 3.4 mmol) was dissolved in ether (9.8
mL), TBAF (1 M in THF) (7 mL, 7 mmol, 2.1 equiv.) was added,
and the solution stirred for 10 m. The solvents were removed
under reduced pressure, and the residue placed under high
vacuum for approximately 2 h. To the resulting colourless solid
was added THF (9.8 mL), and the solution cooled to12 C. MeI
(2.1 mL, 34 mmol, 10 equiv.) was added and the solution stirred
for 72 h. Water (approximately 3 mL) was added and the solu-
tion was allowed to reach room temperature. The solution was
dissolved in ethyl acetate (100 mL), and washed with water (100
mL) and brine (100 mL). The organic layer was dried (magne-
sium sulfate), ltered, and evaporated. The resulting brown oil
was puried by column chromatography on silica gel usingThis journal is © The Royal Society of Chemistry 2019
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View Article Onlinepetroleum ether (40–60 C)/ethyl acetate (9 : 1) as the eluent, to
produce 15a/b as a colourless oil in a 3 : 1 ratio of diastereo-
isomers (1.0273 g, 67%) which could be partially separated. For
the major, rst eluting diastereoisomer 15a: (0.491 g, 32%),
[a]19.5D ¼ 91.3 (c 1.06, CHCl3) (98% ee) nmax (neat)/cm1: 2934,
1781, 1749, 1698; 1H NMR (400 MHz, CDCl3) dH 7.39–7.33 (m,
3H), 7.28–7.23 (m, 2H), 7.01 (d, J ¼ 8.4 Hz, 2H), 6.60 (d, J ¼
8.7 Hz, 2H), 5.38 (d, J ¼ 15.1 Hz, 1H), 5.21 (d, J ¼ 12.3 Hz, 1H),
5.10 (d, J ¼ 12.3 Hz, 1H), 3.86 (t, J ¼ 2.3 Hz, 1H), 3.83 (d, J ¼
15.1 Hz, 1H), 3.74 (s, 3H), 3.58 (dd, J¼ 9.9, 2.1 Hz, 1H), 3.53 (dd,
J¼ 9.9, 2.4 Hz, 1H), 1.56 (s, 3H), 1.12 (s, 9H); 13C NMR (126MHz,
CDCl3) dC 205.0, 170.3, 166.0, 159.3, 135.0, 129.3, 128.8, 128.6,
128.4, 126.7, 114.3, 73.9, 68.2, 65.2, 58.8, 57.2, 55.4, 43.1, 27.3,
15.3; HRMS (NSI-FTMS) m/z [M + H]+ calcd for [C26H32NO6]
+
254.2224, found 454.2218. Determined by HPLC to have 79% ee;
recrystallization from IPA provided a supernatant of 98% ee.
Determination of ee was carried out by HPLC using an AD-H
Chiralpak column 80 : 20 hexane/IPA, 230 nm, 0.8 mL min1,
25 C. For the partially puried, minor, second eluting diaste-
reomer 15b: (0.416 g, 35%), 1H NMR (400 MHz, CDCl3) d 7.38–
7.28 (m, 5H), 7.22 (d, J ¼ 8.6 Hz, 2H), 6.82 (d, J ¼ 8.7 Hz, 2H),
5.25–5.16 (m, 2H), 5.11 (d, J ¼ 12.2 Hz, 1H), 4.31 (d, J ¼ 14.3 Hz,
1H), 3.87 (dd, J ¼ 7.2, 2.6 Hz, 1H), 3.78 (s, 3H), 3.59 (dd, J ¼ 9.7,
2.5 Hz, 1H), 3.48 (dd, J ¼ 9.7, 7.1 Hz, 1H), 1.52 (s, 3H), 1.02 (s,
9H). 13C NMR (101 MHz, CDCl3) d 204.0, 169.6, 165.6, 159.4,
135.0, 130.0, 128.8, 128.7, 128.3, 128.0, 114.2, 74.0, 68.2, 65.5,
62.8, 58.5, 55.4, 44.5, 27.2, 16.7.(2R,4S)-4-Benzyl 2-methyl 2-(tert-butoxymethyl)-1-(4-methoxybenzyl)-4-
methyl-3,5-dioxopyrrolidine-2,4-dicarboxylate 26
Lactam 15a (0.1125 g, 0.25 mmol), in a ame-dried ask, was
dissolved in anhydrous THF (4.5 mL), cooled to 40 C and
placed under an atmosphere of nitrogen. LiHMDS (1 M in THF/
ethylbenzene) (0.56 mL, 0.56 mmol, 2.2 equiv.) and DMPU (0.9
mL, 0.75 mmol, 3 equiv.) were added, and the solution allowed
to stand for 0.5 h. Methyl cyanoformate (0.09 mL, 1.13 mmol,
4.5 equiv.) was added and stirring was continued for 3 h.
Saturated aqueous NH4Cl (0.2 mL) was added, and the mixture
allowed to reach room temperature. Water (20 mL) was added
and the mixture extracted with equal amounts of ethyl acetate
twice. The combined organic extracts were washed with water
(20 mL) and brine (2  20 mL), dried (sodium sulfate), ltered,
and the solvents removed under reduced pressure. The residue
was puried by column chromatography using petroleum ether
(40–60 C)/ethyl acetate (9 : 1) as eluent to yield 26 as a colour-
less crystalline solid (0.0881 g, 69%). Mp 90–94 C [a]25D ¼ +2.85
(c 1.12, CHCl3), nmax (neat)/cm
1: 3434, 2974, 1743; 1H NMR (500
MHz, CDCl3) dH 7.39–7.30 (m, 5H), 7.18 (d, J ¼ 8.7 Hz, 2H), 6.70
(d, J¼ 8.7 Hz, 2H), 5.24 (d, J¼ 12.5 Hz, 1H), 5.16 (d, J ¼ 12.5 Hz,
1H), 4.72 (d, J ¼ 15.3 Hz, 1H), 4.57 (d, J ¼ 15.3 Hz, 1H), 3.83 (d, J
¼ 9.7 Hz, 1H), 3.75 (s, 3H), 3.73 (d, J ¼ 9.7 Hz, 1H), 3.53 (s, 3H),
1.66 (s, 3H), 0.87 (s, 9H); 13C NMR (126 MHz, CDCl3) dC 199.7,
170.7, 166.3, 165.1, 159.0, 135.1, 129.5, 128.7, 128.6, 128.5,
128.0, 113.7, 74.1, 68.1, 61.0, 57.7, 55.5, 53.4, 44.7, 26.8, 18.9;
HRMS (NSI-FTMS) m/z [M + H]+ calcd for [C28H34NO8]
+
512.2279, found 512.2271. Determination of ee was carried outThis journal is © The Royal Society of Chemistry 2019by HPLC using an AD-H Chiralpak column 90 : 10 hexane/IPA,
230 nm, 0.8 mL min1, 25 C.Methyl (2S)-2-anilino-3-tert-butoxypropanoate 33 (ref. 21)
Compound 17 (1.249 g, 5.9 mmol) was dissolved in anhydrous
DCM (40 mL). Phenyl boronic acid (1.447 g, 11.94 mmol, 2
equiv.) was added, together with Cu(OAc)2 (1.2 g, 6.6 mmol, 1.1
equiv.). Triethylamine (1.65 mL, 11.8 mmol, 2 equiv.) and
molecular sieve (4 A˚, 4.4 g) were added, and the mixture was
placed under a static atmosphere of oxygen and stirred for 3
days. Aqueous ammonium hydroxide (1 M, 40 mL) was added,
and the suspension stirred for 40 min and ltered through
diatomaceous earth. The organic layer was removed, and the
aqueous layer extracted with DCM (50 mL). The organic layers
were combined, washed with water (80 mL) and brine (80 mL),
dried (magnesium sulfate), ltered, and the solvents removed
under reduced pressure. The residue was puried by column
chromatography using petroleum ether (40–60 C)/ether 18 : 1
as eluent to yield 33 as a cream coloured solid (0.319 g, 22%).
Recrystallization from petroleum ether gave crystals of 95% ee.
Mp 52–59 C (lit21 47–50 C); [a]22D ¼13.69 (c 1.11, CHCl3) (95%
ee) [a]24D ¼ (lit21 [a]24D ¼ 10.7 (c 1.1, CHCl3) (71% ee)); nmax
(neat)/cm1: 3398, 2975, 1751; 1H NMR (500 MHz, CDCl3) dH
7.20–7.14 (m, 2H), 7.75 (td, J ¼ 7.4, 0.8 Hz, 1H), 6.64 (d, J ¼
8.2 Hz, 2H), 4.62 (s, 1H), 4.20 (t, J¼ 4.1 Hz, 1H), 3.78 (dd, J¼ 8.8,
4.0 Hz, 1H), 3.73 (s, 3H), 3.69 (dd, J ¼ 8.8, 4.2 Hz, 1H), 1.17 (s,
9H); 13C NMR (126 MHz, CDCl3) dC 172.0, 146.9, 129.40, 118.5,
113.8, 73.70, 62.60, 57.4, 52.3, 27.5. Determination of ee was
carried out by HPLC using a Eurocel 01 Knauer column 90 : 10
hexane/IPA, 230 nm, 0.8 mL min1, 25 C.(S)-Benzyl 3-((3-(tert-butoxy)-1-methoxy-1-oxopropan-2-yl)(phenyl)
amino)-3-oxopropanoate 24
Amine 33 (0.2308 g, 0.91 mmol) was dissolved in anhydrous
DCM (7 mL) in a ame-dried ask. The benzyl malonic half
ester 8 (0.47 g, 2.02 mmol, 2.2 equiv.) was added together with
EDAC$HCl (0.467 g, 2.4 mmol 2.7 equiv.), DMAP (0.021 g,
0.17 mmol, 0.19 equiv.) and N-methylmorpholine (0.23 mL,
2.09 mmol, 2.3 equiv.). The mixture was stirred for 16 h under
a nitrogen atmosphere. Aqueous HCl (0.3 mL, 1 M solution) was
added, and the solution diluted with DCM (50mL). The solution
was washed with water (50 mL) and brine (50 mL). The organic
layer was dried (magnesium sulfate), ltered, and the solvents
removed under reduced pressure to give a yellow oil, which was
puried by column chromatography using petroleum ether (40–
60 C)/ethyl acetate (9 : 1 to 7 : 3) as eluent to yield 24 as col-
ourless oil (0.1136 g, 71%). [a]23D ¼ +1.48 (c 0.54, CHCl3) (95% ee)
nmax (neat)/cm
1: 3022, 2974, 1743, 1663; 1H NMR (500 MHz,
CDCl3) dH 7.45 (s, 2H), 7.38–7.28 (m, 8H), 5.10 (s, 2H), 4.69–4.64
(m, 1H), 3.81–3.78 (m, 2H), 3.75 (s, 3H), 3.24 (d, J¼ 15.7 Hz, 1H),
3.20 (d, J ¼ 15.8 Hz, 1H), 1.08 (s, 9H). 13C NMR (126 MHz,
CDCl3) dC 169.8, 167.3, 166.4, 141.5, 135.6, 129.6, 129.5, 128.8,
128.6, 128.5, 128.4, 73.5, 67.1, 62.0, 59.2, 52.4, 42.2, 27.4; HRMS
(NSI-FTMS)m/z [M + H]+ calcd for [C24H30NO6]
+ 428.2068, found
428.2065. Determination of ee was carried out by HPLC using anRSC Adv., 2019, 9, 30019–30032 | 30027
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View Article OnlineAD-H Chiralpak column 80 : 20 hexane/IPA, 230 nm, 0.8
mL min1, 25 C.
(3S,5S)-Benzyl 5-(tert-butoxymethyl)-3-methyl-2,4-dioxo-1-
phenylpyrrolidine-3-carboxylate 25
The Dieckmann cyclization precursor 24 (0.104 g, 0.24 mmol)
was dissolved in ether (0.67 mL), TBAF (1 M in THF), (0.5 mL,
0.5 mmol, 2.1 equiv.) added, and the solution stirred for 10 min.
The solvents were removed under reduced pressure, and the
residue placed under high vacuum for approximately 2 h. THF
(0.67 mL) was added, and the solution cooled to 12 C. MeI
(0.07 mL, 1.12 mmol, 4.7 equiv.) was added, and the suspension
stirred for 72 h. Water (0.1 mL) was added, the solution allowed
to reach room temperature, ethyl acetate (30mL) added, and the
solution washed with water (30 mL) and brine (30 mL). The
organic layer was dried (magnesium sulfate), ltered, and the
solvents removed under reduced pressure. The resulting brown
oil was puried by column chromatography using petroleum
ether (40–60 C)/ethyl acetate (9 : 1) as the eluent. Only the
major diastereoisomer 25 could be isolated (0.0081 g, 8%) mp
121–124 C [a]22D ¼ +14.2 (c 0.81, CHCl3) (87% ee) nmax (neat)/
cm1: 2977, 2253, 1782, 1752, 1702; 1H NMR (500 MHz, CDCl3)
dH 7.44–7.23 (m, 10H), 5.18 (s, 2H), 4.57 (t, J ¼ 2.1 Hz, 1H), 3.68
(dd, J ¼ 9.6, 1.8 Hz, 1H), 3.39 (dd, J ¼ 9.6, 2.4 Hz, 1H), 1.65 (s,
3H), 1.02 (s, 9H); 13C NMR (126 MHz, CDCl3) dC 204.5, 169.5,
165.8, 135.8, 135.2, 129.4, 128.8, 128.5, 127.8, 127.5, 125.6, 73.9,
68.8, 68.0, 59.7, 57.9, 27.2, 15.2; HRMS (NSI-FTMS) m/z [M + H]+
calcd for [C24H28NO5S]
+ 410.1962, found 410.1956. Determina-
tion of ee (87% ee) was carried out by HPLC using an AD-H
Chiralpak column 80 : 20 hexane/IPA, 230 nm, 0.8 mL min1,
25 C.
Potassium 3-methoxy-3-oxopropanoate 34 (ref. 22)
KOH (22.06 g, 393.18 mmol, 1.2 equiv.) was dissolved in
methanol (75 mL). The resulting solution was added to a solu-
tion of dimethyl malonate (38 mL, 332.5 mmol) in methanol (85
mL). A colourless precipitate was formed, which was collected
by vacuum ltration and dried in a vacuum oven to provide
(26.35 g, 51%) of 34 as a colourless solid. Mp: 204–209 C (lit23
204–207 C); nmax (solid)/cm
1: 1726, 1595, 1368; 1H NMR (500
MHz, D2O) dH 3.75 (s, 3H), 3.34 (s, 2H); 13C NMR (101 MHz,
D2O) dC 174.8, 172.6, 53.2, 45.0.
(S)-Methyl 3-(tert-butoxy)-2-(3-methoxy-N-(4-methoxybenzyl)-3-
oxopropanamido)propanoate 21
Amine 19 (0.5558 g, 1.88 mmol) was dissolved in anhydrous
DCM (17.5 mL) in a ame-dried ask. The methyl malonic half
ester 34 (0.692 g, 4.43mmol, 2.4 equiv.) was added together with
EDAC$HCl (1.06 g, 5.53 mmol 2.9 equiv.), DMAP (0.0405 g,
0.33 mmol, 0.18 equiv.) and N-methylmorpholine (0.5 mL,
4.54 mmol, 2.4 equiv.). The mixture was stirred for 24 h under
an atmosphere of nitrogen. Aqueous HCl (1 M, 0.5 mL) was
added, and the solution washed with water (20 mL) and brine
(20 mL). The organic layer was dried (magnesium sulfate),
ltered, and the solvents removed under reduced pressure to
give a yellow oil, which was puried by column chromatography30028 | RSC Adv., 2019, 9, 30019–30032using petroleum ether (40–60 C)/ethyl acetate (8 : 2) as eluent
to yield the desired compound 21 as a pale-yellow oil (0.54 g,
73%). [a]26D ¼ 42.0 (c 1.13, CHCl3); nmax (neat)/cm1: 2973,
1744, 1656, 1514; 1H NMR (400 MHz, CDCl3) dH 7.29 (d, J ¼
7.5 Hz, 2H), 6.91 (d, J ¼ 8.7 Hz, 2H), 4.73 (s, 2H), 4.60 (dd, J ¼
7.6, 3.4 Hz, 1H), 3.93 (dd, J¼ 9.7, 7.6 Hz, 1H), 3.86–3.81 (m, 4H),
3.74 (s, 3H), 3.72 (s, 3H), 3.50 (d, J ¼ 15.3 Hz, 1H), 3.40 (d, J ¼
15.3 Hz, 1H), 1.10 (s, 9H); 13C NMR (101 MHz, CDCl3) dC 169.7,
167.8, 167.4, 159.2, 128.8, 128.1, 114.2, 73.5, 60.7, 59.8, 55.4,
52.5, 52.3, 52.2, 41.3, 27.3; HRMS (NSI-FTMS)m/z [M + H]+ calcd
for [C20H30NO7]
+ 396.2017, found 396.2016.
(3S,5S)-Methyl 5-(tert-butoxymethyl)-1-(4-methoxybenzyl)-
3-methyl-2,4-dioxopyrrolidine-3-carboxylate 22a and (3R,5S)-
methyl 5-(tert-butoxymethyl)-1-(4-methoxybenzyl)-3-methyl-
2,4-dioxopyrrolidine-3-carboxylate 22b
The Dieckmann cyclization precursor 21 (0.2219 g, 0.56
mmol) was dissolved in ether (1.6 mL). TBAF (1 M in THF),
(1.6 mL, 1.6 mmol, 3 equiv.) was added, and the solution
stirred for 5 min. The solvents were removed under reduced
pressure, and the resulting brown oil was dissolved in THF
(1.6 mL). The solution was cooled to 12 C, MeI (0.15 mL,
2.4 mmol, 4.3 equiv.) added, and the suspension stirred for
58 h. Water (1 mL) was added, and the mixture added to
a short silica gel column. The column was eluted with ethyl
acetate. The 3 : 1 mixture of diastereoisomers 22a/b was
collected as a yellow oil and used onto the next step without
further purication (0.1832 g, 87%). Data for the major
diastereoisomer 22a: 1H NMR (400 MHz, CDCl3) dH 7.21 (d, J
¼ 8.5 Hz, 2H), 6.87 (d, J ¼ 8.6 Hz, 2H), 5.35 (d, J ¼ 15.0 Hz,
1H), 3.93 (d, J ¼ 15.0 Hz, 1H), 3.93 (t, J ¼ 2.2 Hz, 1H), 3.80 (s,
3H), 3.73 (s, 3H), 3.60 (dd, J ¼ 9.8, 2.2 Hz, 1H), 3.56 (dd, J ¼
9.9, 2.4 Hz, 1H), 1.53 (s, 3H), 1.11 (s, 9H). 13C NMR (101 MHz,
CDCl3) dC 205.0, 170.5, 166.7, 159.5, 129.5, 127.2, 114.4,
73.9, 65.4, 58.7, 57.4, 55.5, 53.4, 43.4, 27.3, 15.2. Data for the
minor diastereoisomer 22b: 1H NMR (400 MHz, CDCl3) dH
7.23 (d, J ¼ 6.6 Hz, 2H), 6.85 (d, J ¼ 7.2 Hz, 2H), 5.27 (d, J ¼
14.6 Hz, 1H), 4.23 (d, J ¼ 14.5 Hz, 1H), 3.86 (dd, J ¼ 5.8,
2.7 Hz, 1H), 3.79 (s, 3H), 3.75 (s, 3H), 3.69 (m, 2H), 1.52 (s,
3H), 1.17 (s, 9H). 13C NMR (101 MHz, CDCl3) dC 204.0, 169.0,
166.3, 159.5, 129.0, 127.8, 114.3, 74.0, 65.1, 61.3, 58.3, 55.4,
53.4, 44.2, 27.4, 17.4. Data for both diastereoisomers: nmax
(neat)/cm1: 2974, 1782, 1750, 1698, 1514; HRMS (NSI-
FTMS) m/z [M + H]+ calcd for [C20H28NO6]
+ 378.1911, found
378.1913.
(3S,5S)-Methyl 5-(tert-butoxymethyl)-3-methyl-2,4-dioxopyrrolidine-3-
carboxylate 23a and (3R,5S)-methyl 5-(tert-butoxymethyl)-3-methyl-
2,4-dioxopyrrolidine-3-carboxylate 23b
The mixture of diastereoisomers 22a/b (0.1251 g, 0.331
mmol) was dissolved in a MeCN/H2O mixture (3 : 1) (3.5 mL).
CAN (0.9 g, 1.64 mmol, 5 equiv.) was added, and the solution
stirred vigorously until consumption of the starting material
had occurred (approx. 1.5 h). Ethyl acetate (25 mL) was
added, and the solution washed with water (25 mL). The
aqueous layer was extracted with ethyl acetate (25 mL). TheThis journal is © The Royal Society of Chemistry 2019
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
Se
pt
em
be
r 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
0/
4/
20
19
 1
:1
1:
29
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinecombined organic layers were washed with water (25 mL) and
brine (25 mL), dried (magnesium sulfate), ltered, and the
solvents removed under reduced pressure. The crude mate-
rial was puried by column chromatography using petroleum
ether (40–60 C)/ethyl acetate (8 : 2–7 : 3) as the eluent to give
a mixture of partially separable diastereoisomers (0.0483 g,
57% total) from which only 23a could be obtained uncon-
taminated (0.01 g, 12%). Data for the major diastereoisomer
23a: mp 111–116 C; [a]24D ¼46.2 (c 0.91, CHCl3); nmax (neat)/
cm1: 3234, 2976, 1785, 1750, 1706; 1H NMR (400 MHz,
CDCl3) dH 6.72 (d, J ¼ 39.7 Hz, 1H), 4.18 (dd, J ¼ 9.2, 3.6 Hz,
1H), 3.77–3.69 (m, 4H), 3.53 (t, J ¼ 9.1 Hz, 1H), 1.55 (s, 3H),
1.19 (s, 9H); 13C NMR (101 MHz, CDCl3) dC 204.4, 171.4,
166.2, 74.3, 63.4, 62.4, 58.5, 53.6, 27.5, 16.7; HRMS (NSI-
FTMS) m/z [M + H]+ calcd for [C12H20NO5]
+ 258.1336, found
258.1339. Data for the minor diastereoisomer 23b: 1H NMR
(400 MHz, CDCl3) dH 6.73–6.31 (m, 1H), 4.31 (t, J ¼ 3.6 Hz,
1H), 3.74 (s, 3H), 3.61 (d, J ¼ 3.6 Hz, 2H), 1.51 (s, 3H), 1.14 (s,
9H); 13C NMR (101 MHz, CDCl3) dC 205.2, 172.2, 166.3, 74.1,
63.5, 61.0, 58.6, 53.6, 27.4, 15.1.(2R,4R)-Methyl 2-(tert-butoxymethyl)-1-(4-methoxybenzyl)-
4-methyl-4-(methylthio)-3,5-dioxopyrrolidine-2-carboxylate
28a and (2R,4S)-methyl 2-(tert-butoxymethyl)-1-(4-methoxybenzyl)-
4-methyl-4-(methylthio)-3,5-dioxopyrrolidine-2-carboxylate 28b
Methyl ester 26 (0.1426 g, 0.31 mmol) was dissolved in THF (0.7
mL), and the solution heated to 35 C. A micro-spatula of
Pd(OH)2/C was added and the stirred solution placed under
a static atmosphere of hydrogen. Aer 16 h the solution was
ltered through diatomaceous earth and washed with DCM.
The solvents were removed under reduced pressure to produce
a foam, which was dissolved in anhydrous DCM (0.5 mL) in
a ame-dried ask. 27 (0.1090 g, 0.53 mmol, 1.7 equiv.) was
added together with triethylamine (0.05 mL, 0.35 mmol, 1.1
equiv.). The solution was stirred at 20 C for 5 h under an
atmosphere of nitrogen, and the solvents removed under
reduced pressure to give a yellow oil, which was puried by
column chromatography using petroleum ether (40–60 C)/ethyl
acetate (9 : 1) as the eluent to yield a 4 : 1 mixture of inseparable
diastereoisomers 28a/b as a pale-yellow oil (0.127 g, 70%). Data
for the major diastereoisomer 28a: 1H NMR (500 MHz, CDCl3)
dH 7.26 (d, J ¼ 8.7 Hz, 2H), 6.82 (d, J ¼ 8.7 Hz, 2H), 4.74 (d, J ¼
15.2 Hz, 1H), 4.44 (d, J ¼ 15.2 Hz, 1H), 3.89 (d, J ¼ 9.6 Hz, 1H),
3.78 (s, 3H), 3.72 (d, J ¼ 9.6 Hz, 1H), 3.47 (s, 3H), 2.16 (s, 3H),
1.57 (s, 3H), 1.01 (s, 9H); 13C NMR (101 MHz, CDCl3) d 201.6,
172.5, 166.2, 159.3, 130.3, 128.4, 113.8, 76.2, 74.3, 60.3, 55.4,
52.0, 49.7, 44.1, 27.1, 18.0, 12.6. Data for the minor diastereo-
isomer 28b: 1H NMR (500 MHz, CDCl3) dC 7.26 (d, J ¼ 8.7 Hz,
2H), 6.82 (d, J¼ 8.7 Hz, 2H), 4.84 (d, J¼ 15.1 Hz, 1H), 4.36 (d, J¼
15.1 Hz, 1H), 4.00 (d, J ¼ 10.2 Hz, 1H), 3.86 (d, J ¼ 10.2 Hz, 1H),
3.78 (s, 3H), 3.37 (s, 3H), 2.20 (s, 3H), 1.61 (s, 3H), 1.08 (s, 9H);
13C NMR (101 MHz, CDCl3) d 203.4, 172.7, 166.7, 159.3, 130.4,
128.0, 113.8, 75.8, 74.4, 59.7, 55.4, 53.1, 50.7, 44.2, 27.1, 20.7,
12.9. Data for both diastereoisomers: nmax (neat)/cm
1: 3020,
1741, 1699; HRMS (NSI-FTMS) m/z [M + H]+ calcd for
[C21H30NO6S]
+ 424.1788, found 424.1790.This journal is © The Royal Society of Chemistry 2019(2R,4R)-Methyl 2-(hydroxymethyl)-1-(4-methoxybenzyl)-4-methyl-4-
(methylthio)-3,5-dioxopyrrolidine-2-carboxylate 29a (ref. 17) and
(2R,4S)-methyl 2-(hydroxymethyl)-1-(4-methoxybenzyl)-4-methyl-4-
(methylthio)-3,5-dioxopyrrolidine-2-carboxylate 29b
The 4 : 1 mixture of inseparable diastereoisomers 28a/
b (0.0297 g, 0.07 mmol) was dissolved in anhydrous DCM (0.15
mL) in a ame-dried ask, and TFA (0.15 mL) added. The
solution was stirred under nitrogen for 1.5 h until TLC showed
complete consumption of starting material. The solution was
diluted with DCM (50 mL), and washed with water (50 mL). The
organic layer was washed with aqueous NaHCO3 (50 mL), dried
(sodium sulfate), ltered, and the solvents removed under
reduced pressure to give a brown residue, which was puried by
column chromatography using petroleum ether (40–60 C)/ethyl
acetate (2 : 1) as eluent to yield 29a/b as a 2 : 1 mixture of
inseparable isomers (0.0195 g, 76%). Data for the major dia-
stereomer 29a: 1H NMR (400 MHz, CDCl3) dH 7.33 (d, J¼ 8.6 Hz,
2H), 6.86 (d, J¼ 8.6 Hz, 2H), 5.08 (d, J¼ 15.2 Hz, 1H), 4.35 (d, J¼
15.2 Hz, 1H), 4.17 (d, J ¼ 12.0 Hz, 1H), 3.79 (d, J ¼ 12.8 Hz, 4H),
3.67 (s, 3H), 2.12 (s, 3H), 1.54 (s, 3H); 13C NMR (101MHz, CDCl3)
dC 199.1, 172.2, 165.7, 159.7, 129.9, 128.8, 114.6, 77.6, 61.8, 55.4,
53.4, 49.7, 44.3, 16.9, 12.4. Analysis by HPLC determined the ee
to be 58% ee. Data for the minor diastereomer 29b: 1H NMR
(400 MHz, CDCl3) dH 7.27 (d, J ¼ 9.7 Hz, 2H), 6.84 (d, J ¼ 7.2 Hz,
2H), 4.68 (d, J ¼ 15.0 Hz, 1H), 4.60 (d, J ¼ 15.0 Hz, 1H), 4.20 (d, J
¼ 11.8 Hz, 1H), 4.07 (d, J ¼ 12.6 Hz, 1H), 3.77 (s, 3H), 3.42 (s,
3H), 2.17 (s, 3H), 1.61 (s, 3H); 13C NMR (101 MHz, CDCl3) dC
200.3, 172.2, 166.7, 159.6, 130.3, 127.9, 114.3, 76.6, 62.01, 55.4,
53.4, 49.5, 44.4, 18.1, 12.2. Analysis by HPLC determined the ee
to be 41% ee. Data for both diastereoisomers: nmax (neat)/cm
1:
3419, 3000, 2932, 1776, 1742, 1699; HRMS (NSI-FTMS) m/z [M +
H]+ calcd for [C17H22NO6S]
+ 368.1162, found 368.1165. Deter-
mination of ee was carried out by HPLC using an AD-H Chir-
alpak column, 80 : 20 hexane/IPA, 230 nm, 0.8 mLmin1, 25 C.(R)-Methyl 2-(tert-butoxymethyl)-1-(4-methoxybenzyl)-4,4-
dimethyl-3,5-dioxopyrrolidine-2-carboxylate 30
Methyl ester 26 (0.0832 g, 0.16 mmol) was dissolved in THF (0.5
mL) and the solution heated to 35 C. Pd(OH)2/C (20% nomi-
nally) (0.604 g) was added and the solution placed under a static
atmosphere of hydrogen. Aer 16 h the solution was ltered
through diatomaceous earth and washed through with DCM.
The solvents were removed under reduced pressure to produce
a foam which was dissolved in DCM (0.6 mL). The solution was
stirred under an atmosphere of nitrogen and triethylamine
(0.04 mL, 0.29 mmol, 1.8 equiv.) added. Aer 15 min, MeI was
added (0.04 mL 0.64 mmol, 4 equiv.), and the solution stirred
for a further 5 h, diluted with DCM (50 mL), and washed with
water (50 mL) and brine (50 mL). The organic layer was dried
(sodium sulfate), ltered, the solvents were removed under
reduced pressure, and the residue puried by column chro-
matography using petroleum ether (40–60 C)/ethyl acetate
(8 : 2) as eluent to produce a pink oil. The oil was dissolved in
DCM and washed with a saturated sodium thiosufate solution
until the organic layer became colourless, dried (sodium
sulfate), ltered, and the solvents removed under reducedRSC Adv., 2019, 9, 30019–30032 | 30029
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View Article Onlinepressure to produce 30 as a colourless oil (0.0286 g, 46% over
the 2 steps). [a]22D ¼ +50 (c 0.31, CHCl3); nmax (neat)/cm1: 3019,
2978, 1779, 1742; 1H NMR (500 MHz, CDCl3) dH 7.22 (d, J ¼
8.7 Hz, 2H), 6.81 (d, J ¼ 8.7 Hz, 2H), 4.87 (d, J ¼ 15.1 Hz, 1H),
4.19 (d, J ¼ 15.1 Hz, 1H), 3.89 (d, J ¼ 9.8 Hz, 1H), 3.77 (s, 3H),
3.75 (d, J ¼ 9.8 Hz, 1H), 3.31 (s, 3H), 1.34 (s, 3H), 1.28 (s, 3H),
1.05 (s, 9H); 13C NMR (126 MHz, CDCl3) dC 209.1, 177.3, 166.9,
159.3, 130.5, 128.2, 113.8, 75.8, 74.1, 58.9, 55.4, 52.8, 46.1, 43.3,
27.2, 22.2, 20.6; HRMS (NSI-FTMS) m/z [M + H]+ calcd for
[C21H30NO6]
+ 392.2068, found 392.2068. Determination of ee
was carried out by HPLC using an Eurocel 01 Knauer column,
95 : 5 hexane/IPA, 230 nm, 0.8 mL min1, 25 C.
(R)-Methyl 2-(hydroxymethyl)-1-(4-methoxybenzyl)-4,4-
dimethyl-3,5-dioxopyrrolidine-2-carboxylate 31
Lactam 30 (0.0109 g, 0.027 mmol) was dissolved in dry DCM (0.1
mL), and TFA (0.1 mL) added. The solution was stirred under
nitrogen for 1.5 h until TLC showed complete consumption of
starting material. The solution was diluted to 50 mL with DCM
and washed with water (50 mL). The organic layer was washed
with a saturated NaHCO3 solution (50 mL), dried (sodium
sulfate), ltered, and the solvents removed under reduced
pressure to give a colourless solid, which was puried by
column chromatography using petroleum ether (40–60 C)/ethyl
acetate (2 : 1) as eluent to yield the deprotected alcohol 31 as
a gum (0.0062 g, 67%). [a]24D ¼ 7.74 (c 0.62, CHCl3) (86% ee)
nmax (neat)/cm
1: 3396, 2919, 1778, 1742, 1678; 1H NMR (500
MHz, CDCl3) dH 7.30 (d, J ¼ 8.7 Hz, 2H), 6.86 (d, J ¼ 8.7 Hz, 2H),
4.89 (d, J ¼ 15.1 Hz, 1H), 4.31 (d, J ¼ 15.1 Hz, 1H), 4.14 (dd, J ¼
12.3, 8.6 Hz, 1H), 3.85 (dd, J ¼ 12.3, 4.4 Hz, 1H), 3.79 (s, 3H),
3.55 (s, 3H), 1.35 (s, 3H), 1.28 (s, 3H), 1.17 (dd, J ¼ 8.6, 4.5 Hz,
1H); 13C NMR (126 MHz, CDCl3) dC 208.3, 177.3, 166.4, 159.6,
130.1, 128.7, 114.5, 77.3, 60.8, 55.4, 53.2, 46.1, 43.7, 22.0, 20.5;
HRMS (NSI-FTMS) m/z [M + H]+ calcd for [C17H22NO6]
+
336.1442, found 336.1443. Determination of ee (86% ee) was
carried out by HPLC using an AD-H Chiralpak column, 80 : 20
hexane/IPA, 230 nm, 0.8 mL min1, 25 C.
(2R,3R,4R)-Methyl 2-(tert-butoxymethyl)-3-hydroxy-1-(4-
methoxybenzyl)-4-methyl-4-(methylthio)-5-oxopyrrolidine-
2-carboxylate 32a and (2R,3S,4S)-methyl 2-(tert-butoxymethyl)-3-
hydroxy-1-(4-methoxybenzyl)-4-methyl-4-(methylthio)-5-oxopyrrolidine-
2-carboxylate 32b
The mixture of diastereoisomers 28a/b (0.1407 g, 0.33 mmol)
was dissolved in ethanol (9 mL) and the solution cooled with an
ice bath. Sodium borohydride (0.0073 g, 0.19 mmol, 0.6 equiv.)
was added, and the mixture stirred for 20 min. Water (40 mL)
was added, and the resulting solution extracted with ethyl
acetate (3  40 mL). The combined organic extracts were
washed with brine (120 mL), dried (sodium sulfate), ltered,
and the solvents removed under reduced pressure. The residue
was puried using column chromatography using petroleum
ether (40–60 C)/ethyl acetate (8 : 2–2 : 1) as eluent to provide
two separable diastereoisomers as gums, 32a, the rst eluting
diastereoisomer (0.0764 g, 54%) and 32b, the second (0.0181 g,
13%). Analysis by chiral HPLC showed the ees of the30030 | RSC Adv., 2019, 9, 30019–30032diastereoisomers to be 67% and 66% ee respectively. Diaste-
reomer 32a upon recrystallization from IPA gave 0.0511 g of
material from the supernatant at 99% ee. Data for major, rst
eluting diastereoisomer 32a: [a]23D ¼ +6.2 (c 0.71, CHCl3) (99%
ee) nmax (neat)/cm
1: 3418, 2973, 2926, 1743, 1697; 1H NMR (500
MHz, CDCl3) dH 7.24 (d, J ¼ 8.7 Hz, 2H), 6.81 (d, J ¼ 8.7 Hz, 2H),
4.71 (d, J ¼ 15.2 Hz, 1H), 4.46 (d, J ¼ 15.2 Hz, 1H), 3.99–3.87 (m,
2H), 3.82 (d, J¼ 9.7 Hz, 1H), 3.78 (s, 3H), 3.65 (s, 3H), 3.44 (d, J¼
9.7 Hz, 1H), 2.12 (s, 3H), 1.60 (s, 3H), 1.04 (s, 9H); 13C NMR (126
MHz, CDCl3) dC 173.0, 172.1, 158.9, 130.4, 129.6, 113.7, 77.9,
74.1, 70.7, 62.8, 55.4, 53.4, 52.5, 45.2, 27.2, 22.9, 12.3; HRMS
(NSI-FTMS) m/z [M + H]+ calcd for [C21H32NO6S]
+ 426.1945,
found 426.1942. Data for the minor, second eluting diaste-
reomer 32b: [a]22D ¼ +5.26 (c 0.38, CHCl3) (66% ee) nmax (neat)/
cm1: 3385, 3016, 2975, 1743, 1686; 1H NMR (500 MHz, CDCl3)
d 7.18 (d, J ¼ 8.6 Hz, 2H), 6.81 (d, J ¼ 8.7 Hz, 2H), 4.77 (d, J ¼
15.5 Hz, 1H), 4.43 (d, J ¼ 15.5 Hz, 1H), 4.32 (s, 1H), 3.96 (d, J ¼
9.6 Hz, 1H), 3.77 (s, 3H), 3.75 (s, 1H), 3.67 (d, J ¼ 9.7 Hz, 1H),
3.64 (s, 3H), 2.19 (s, 3H), 1.53 (s, 3H), 1.02 (s, 9H); 13C NMR (126
MHz, CDCl3) d 173.8, 171.7, 158.8, 130.3, 128.9, 113.7, 78.0,
74.4, 71.6, 62.1, 55.7, 55.4, 52.7, 45.3, 27.1, 22.6, 12.7; HRMS
(NSI-FTMS) m/z [M + H]+ calcd for [C21H32NO6S]
+ 426.1945,
found 426.1945. Determination of ee was carried out by HPLC
using an AD-H Chiralpak column, 90 : 10 hexane/IPA, 230 nm,
0.8 mL min1, 25 C.(2R,3R,4R)-Methyl 3-hydroxy-2-(hydroxymethyl)-1-(4-methoxybenzyl)-4-
methyl-4-(methylthio)-5-oxopyrrolidine-2-carboxylate 13 (ref. 18)
Alcohol 32a (0.0427 g, 0.1 mmol) was dissolved in anhydrous
DCM (0.21 mL) in a ame-dried ask. TFA (0.21 mL) was added,
and the mixture stirred under an atmosphere of nitrogen until
TLC showed complete consumption of starting material (about
1.5 h). The mixture was diluted with DCM (20 mL) and washed
with water (20 mL). The aqueous layer was extracted with DCM
(20 mL), and the combined organic layers were washed with
saturated aqueous NaHCO3 (20 mL) and brine (20 mL), dried
(sodium sulfate), ltered, and the solvents removed under
reduced pressure. The residue was puried by column chro-
matography using petroleum ether (40–60 C)/ethyl acetate 1 : 1
as eluent to yield 13 as a colourless solid (0.0279 g, 75%). Mp
128–130 C (lit18 129 C); [a]23D ¼ 33.84 (c 0.13, CHCl3) (lit18
[a]23D ¼ 41.8 (c 0.1, CHCl3)) nmax (neat)/cm1: 3416, 2925, 2852,
1737, 1675; 1H NMR (500 MHz, CDCl3) dH 7.29 (d, J ¼ 8.5 Hz,
2H), 6.85 (d, J¼ 8.7 Hz, 2H), 5.11 (d, J¼ 15.3 Hz, 1H), 4.13 (d, J¼
7.7 Hz, 1H), 4.05 (d, J ¼ 15.3 Hz, 1H), 3.85–3.77 (m, 5H), 3.76 (s,
3H), 3.67 (d, J ¼ 8.1 Hz, 1H), 2.14 (s, 3H), 1.61 (s, 3H); 13C NMR
(126 MHz, CDCl3) dC 173.5, 171.6, 159.5, 129.8, 129.6, 114.6,
76.8, 72.4, 62.5, 55.4, 53.4, 52.9, 44.8, 22.9, 12.4; HRMS (NSI-
FTMS) m/z [M + H]+ calcd for [C17H24NO6S]
+ 370.1319, found
370.1320. Determination of ee was carried out by HPLC using an
AD-H Chiralpak column, 80 : 20 hexane/IPA, 230 nm, 0.8
mL min1, 25 C.Conﬂicts of interest
There are no conicts to declare.This journal is © The Royal Society of Chemistry 2019
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